Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy with glutaminase inhibitors and immuno-oncology agents

Combination therapy with glutaminase inhibitors and immuno-oncology agents

US Patent 10940148 · Granted Mar 9, 2021

Estimated economic value: $4,102,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Arginase inhibitor combination therapies2022
Arginase inhibitor combination therapies2022
2,4-pyrimidinediamine compounds and their uses2021
Compositions and methods for inhibiting arginase activity2021
2,4-pyrimidinediamine compounds and their uses2020
2,4-pyrimidinediamine compounds and their uses2020
2,4-pyrimidinediamine compounds and their uses2020
Combination therapy with peptide epoxyketones2020
Combination therapy with peptide epoxyketones2020
Treatment of lung cancer with inhibitors of glutaminase2019
Compositions and methods for inhibiting arginase activity2019
2,4-pyrimidinediamine compounds and their uses2019